Inflammatory milieu is associated with cancer progression and angiogenesis in different types of tumors, such as gastrointestinal, breast, prostate, and head and neck cancers. Among the inflammatory pathways, numerous evidence indicates that the cyclooxygenase-2/microsomal prostaglandin E synthase-1/prostaglandin E2/E Prostaglandin type receptor (COX-2/mPGES-1/PGE2/EPs) signaling supports epithelial tumor aggressiveness promoting cell growth, epithelial-mesenchymal transition (EMT), and sternness. Further, PGE2 modulates pro-oncogenic and pro-angiogenic pathways such as EGFR and FGFR-1. In this review, we discuss the role of PGE2 and its network of partner proteins in tumor progression and angiogenesis. We also discuss major COX-2/mPGES-1 and EPs therapeutic advances that have been made over the past few years in targeting tumorigenesis and angiogenesis.

Donnini, S., Finetti, F., Terzuoli, E., Bazzani, L., Ziche, M. (2014). Targeting PGE2 Signaling in Tumor Progression and Angiogenesis. FORUM ON IMMUNOPATHOLOGICAL DISEASES AND THERAPEUTICS, 5, 223-232 [10.1615/ForumImmunDisTher.2015014095].

Targeting PGE2 Signaling in Tumor Progression and Angiogenesis

DONNINI, SANDRA;FINETTI, FEDERICA;TERZUOLI, ERIKA;BAZZANI, LORENZO;ZICHE, MARINA
2014-01-01

Abstract

Inflammatory milieu is associated with cancer progression and angiogenesis in different types of tumors, such as gastrointestinal, breast, prostate, and head and neck cancers. Among the inflammatory pathways, numerous evidence indicates that the cyclooxygenase-2/microsomal prostaglandin E synthase-1/prostaglandin E2/E Prostaglandin type receptor (COX-2/mPGES-1/PGE2/EPs) signaling supports epithelial tumor aggressiveness promoting cell growth, epithelial-mesenchymal transition (EMT), and sternness. Further, PGE2 modulates pro-oncogenic and pro-angiogenic pathways such as EGFR and FGFR-1. In this review, we discuss the role of PGE2 and its network of partner proteins in tumor progression and angiogenesis. We also discuss major COX-2/mPGES-1 and EPs therapeutic advances that have been made over the past few years in targeting tumorigenesis and angiogenesis.
2014
Donnini, S., Finetti, F., Terzuoli, E., Bazzani, L., Ziche, M. (2014). Targeting PGE2 Signaling in Tumor Progression and Angiogenesis. FORUM ON IMMUNOPATHOLOGICAL DISEASES AND THERAPEUTICS, 5, 223-232 [10.1615/ForumImmunDisTher.2015014095].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1007519
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo